Alkermes’ Commercial Data Governance Journey: Enhancing Data Use to Support the Launch of a New Medication

Data Governance is a Journey — Photo by Author David E. Sweenor

Note: This blog was created from a presentation delivered at Snowflake Summit 2024 by Bo Yang and me. It represents Alkermes’ experience implementing the Alation Data Intelligence solution.

Key Insights

1. Alkermes, a neuroscience-focused biopharmaceutical company, sought to improve its Commercial data management capabilities in order to support a new product launch.
2. To manage the complexity of its data ecosystem, Alkermes implemented the Alation Data Intelligence Platform. This platform enables users across the Commercial organization to easily find, understand, and trust data, ultimately driving data-driven decision-making.
3. Successful adoption required involving cross-functional stakeholders from the start, providing sufficient training, ensuring both bottom-up and top-down organizational change, and adapting with agility as strategies evolved.

“Everything that we do, from our drug discovery to data management and governance, is all about making sure that we can make an impact to patients we seek to serve.”

- Bo Yang, Director of Commercial Data Strategy & Governance, Alkermes

Introduction